Team:Paris/Addressing testing

From 2009.igem.org

(Difference between revisions)
(→WetLab - Addressing the message)
(→WetLab - Addressing the message)
Line 161: Line 161:
|- style="background: #d8d8d8; text-align: center;"
|- style="background: #d8d8d8; text-align: center;"
-
|bgcolor="#F8F8F8"|'''digestion:'''  
+
|bgcolor="#F8F8F8"|'''Digestion:'''  
ClyA Cterm S/P
ClyA Cterm S/P
Line 173: Line 173:
-
|bgcolor="#E0E3FE"|'''digestion:'''  
+
|bgcolor="#E0E3FE"|'''Digestion:'''  
ClyA Cter-RFP Nter vector PSB1A3 E/X
ClyA Cter-RFP Nter vector PSB1A3 E/X
-
|bgcolor="#CBD1FD"|'''digestion:'''  
+
|bgcolor="#CBD1FD"|'''Digestion:'''  
-
-
-
|bgcolor="#BCCDFD"|'''digestion:'''  
+
|bgcolor="#BCCDFD"|'''Digestion:'''  
-
-
|- style="background: #bebebe; text-align: center;"   
|- style="background: #bebebe; text-align: center;"   
-
|bgcolor="#F8F8F8"| '''verification digestion:'''
+
|bgcolor="#F8F8F8"| '''Verification digestion:'''
ok
ok
-
|bgcolor="#E0E3FE"|'''verification digestion:'''
+
|bgcolor="#E0E3FE"|'''Verification digestion:'''
ok
ok
-
|bgcolor="#CBD1FD"|'''verification digestion:'''
+
|bgcolor="#CBD1FD"|'''Verification digestion:'''
-
-
-
|bgcolor="#BCCDFD"|'''verification digestion:'''
+
|bgcolor="#BCCDFD"|'''Verification digestion:'''
-
-
Line 202: Line 202:
|- style="background: #d8d8d8; text-align: center;"
|- style="background: #d8d8d8; text-align: center;"
-
|bgcolor="#F8F8F8"|'''ligation:'''  
+
|bgcolor="#F8F8F8"|'''Ligation:'''  
ClyA Cter-RFP Nter  vector PSB1A3
ClyA Cter-RFP Nter  vector PSB1A3
-
|bgcolor="#E0E3FE"|'''ligation:'''  
+
|bgcolor="#E0E3FE"|'''Ligation:'''  
PBAD  E/S  ClyA Cter-RFP Nter PSB1A3 E/X (x2)
PBAD  E/S  ClyA Cter-RFP Nter PSB1A3 E/X (x2)
Line 213: Line 213:
PBAD  S/P  ClyA Cter-RFP Nter PSB2K3  X/P (x2)
PBAD  S/P  ClyA Cter-RFP Nter PSB2K3  X/P (x2)
-
|bgcolor="#CBD1FD"|'''ligation:'''
+
|bgcolor="#CBD1FD"|'''Ligation:'''
-
-
-
|bgcolor="#BCCDFD"|'''ligation:'''
+
|bgcolor="#BCCDFD"|'''Ligation:'''
   
   
-
-
|- style="background: #bebebe; text-align: center;"   
|- style="background: #bebebe; text-align: center;"   
-
|bgcolor="#F8F8F8"| '''PCR colo :'''
+
|bgcolor="#F8F8F8"| '''PCR colony :'''
ok
ok
-
|bgcolor="#E0E3FE"|'''PCR colo :'''
+
|bgcolor="#E0E3FE"|'''Colony PCR :'''
ok
ok
-
|bgcolor="#CBD1FD"|'''PCR colo :'''
+
|bgcolor="#CBD1FD"|'''Colony PCR :'''
-
-
-
|bgcolor="#BCCDFD"|'''PCR colo :'''
+
|bgcolor="#BCCDFD"|'''Colony PCR :'''
-
-
Line 239: Line 239:
|- style="background: #d8d8d8; text-align: center;"
|- style="background: #d8d8d8; text-align: center;"
-
|bgcolor="#F8F8F8"|'''miniprep:'''
+
|bgcolor="#F8F8F8"|'''Miniprep:'''
clone :
clone :
-
|bgcolor="#E0E3FE"|'''miniprep:'''
+
|bgcolor="#E0E3FE"|'''Miniprep:'''
clone :
clone :
-
|bgcolor="#CBD1FD"|'''miniprep:'''
+
|bgcolor="#CBD1FD"|'''Miniprep:'''
-
-
-
|bgcolor="#BCCDFD"|'''miniprep:'''
+
|bgcolor="#BCCDFD"|'''Miniprep:'''
-
-
Line 256: Line 256:
|- style="background: #bebebe; text-align: center;"   
|- style="background: #bebebe; text-align: center;"   
-
|bgcolor="#F8F8F8"|'''sequencing :'''
+
|bgcolor="#F8F8F8"|'''Sequencing :'''
ok
ok
-
|bgcolor="#E0E3FE"|'''sequencing :'''
+
|bgcolor="#E0E3FE"|'''Sequencing :'''
ok
ok
-
|bgcolor="#CBD1FD"|'''sequencing :'''
+
|bgcolor="#CBD1FD"|'''Sequencing :'''
-
-
-
|bgcolor="#BCCDFD"|'''sequencing :'''
+
|bgcolor="#BCCDFD"|'''Sequencing :'''
-
-
|- style="background: #d8d8d8; text-align: center;"   
|- style="background: #d8d8d8; text-align: center;"   
-
|bgcolor="#F8F8F8"| '''stock glycerol:'''
+
|bgcolor="#F8F8F8"| '''Stock glycerol:'''
ClyA CTer: S47(clone 3) and S48(clone 7)
ClyA CTer: S47(clone 3) and S48(clone 7)
Line 283: Line 283:
-
|bgcolor="#E0E3FE"|'''stock glycerol'''
+
|bgcolor="#E0E3FE"|'''Stock glycerol'''
Cly A(Cter)-(Nter)RFP: S72(clone 8)
Cly A(Cter)-(Nter)RFP: S72(clone 8)
-
|bgcolor="#CBD1FD"|'''stock glycerol'''
+
|bgcolor="#CBD1FD"|'''Stock glycerol'''
-
-
-
|bgcolor="#BCCDFD"|'''stock glycerol'''
+
|bgcolor="#BCCDFD"|'''Stock glycerol'''
-
-

Revision as of 21:45, 21 October 2009

iGEM > Paris > WetLab > Addressing


WetLab - Addressing the message


global constructions :

The green color means the experiment was a success
plasmid = PSB3T5


Time required : A lot !!!!!



Experiments ran :

column 1 column 2 column 3 column 4
PCR :

pBAD: plate 2008


ClyA Cterm matrix : F4

Oligo :O10 and O31 TM :55°C


mRFP Nterm plasmid : pSB1A3

Oligo :O57 and O58 TM :


ClyA Nterm matrix : F4

Oligo : O32 and O9 TM :55°C


mRFP Cterm matrix : pSB1A3

Oligo :O59 and O60 TM :


PCR :

-

PCR :

-

PCR :

-

Verification on gel :

ok

Verification on gel :

-

Verification on gel :

-

Verification on gel :

-

Purification on gel :

ok

Purification on gel :

-

Purification on gel :

-

Purification on gel :

-

Digestion:

ClyA Cterm S/P


RFP Nterm X/P


pBAD vector : ? E/S


Digestion:

ClyA Cter-RFP Nter vector PSB1A3 E/X

Digestion:

-

Digestion:

-

Verification digestion:

ok

Verification digestion:

ok

Verification digestion:

-

Verification digestion:

-


Ligation:

ClyA Cter-RFP Nter vector PSB1A3

Ligation:

PBAD E/S ClyA Cter-RFP Nter PSB1A3 E/X (x2)


PBAD S/P ClyA Cter-RFP Nter PSB2K3 X/P (x2)

Ligation:

-

Ligation:

-

PCR colony :

ok

Colony PCR :

ok

Colony PCR :

-

Colony PCR :

-


Miniprep:

clone :

Miniprep:

clone :

Miniprep:

-

Miniprep:

-


Sequencing :

ok

Sequencing :

ok

Sequencing :

-

Sequencing :

-

Stock glycerol:

ClyA CTer: S47(clone 3) and S48(clone 7)

ClyA Nter: S72

RFP Cter: S55 (Clone 3)

RFP Nter: S56 (Clone 3)


Stock glycerol

Cly A(Cter)-(Nter)RFP: S72(clone 8)

Stock glycerol

-

Stock glycerol

-



Functional Testing:

PBAD ClyA RFP was transformed into Top10 bacteria in order to localize the fluorescence, we are supposed to have a superior fluorescence in the membrane.


PBAD ClyA RFP on PSB3T5 was transformed into Delta Tol bacteria , in this case we are supposed to see fluorescent vesicles went the medium contains 1 % arabinose , and to have no fluorescent on 1% glucose.


Export system

We finally thought that it won't be neccesary to overexpress the Tat system, nevertheless we have run a few experiments before starting to focus on others parts of the project.


Time required : A week.



Experiments ran :

column 1 column 2 column 3 column 4


PCR :

TatABCE matrix :

PCR : PCR : PCR :
Verification on gel :

ok

Verification on gel :

-

Verification on gel :

-

Verification on gel :

-

Purification on gel :

ok

Purification on gel :

-

Purification on gel :

-

Purification on gel :

-


digestion:

TatABCE

digestion: digestion: digestion:
verification digestion:

ok

verification digestion:

-

verification digestion:

-

verification digestion:

-


ligation:

TatABCE

ligation: ligation: ligation:
PCR colo :

ok

PCR colo :

-

PCR colo :

-

PCR colo :

-

miniprep:

STOPPED

miniprep:

-

miniprep:

-

miniprep:

-

sequencing :

-

sequencing :

-

sequencing :

-

sequencing :

-

stock glycerol:

-

stock glycerol

-

stock glycerol

-

stock glycerol

-


Retrieved from "http://2009.igem.org/Team:Paris/Addressing_testing"